Rigel Pharmaceuticals RIGL Single reportable segment — Net Income
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's single reportable segment — net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Rigel Pharmaceuticals's single reportable segment — net income?
- Rigel Pharmaceuticals (RIGL) reported single reportable segment — net income of $8.65M in Q1 2026.
- What does single reportable segment — net income mean?
- Calculated as the total revenue minus all operating expenses, taxes, and interest costs for the reportable segment. This is the primary measure of the segment's overall financial health and profitability.